Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases

PDZ (postsynaptic density (PSD95), discs large (Dlg), and zonula occludens (ZO-1)-dependent interactions are widely distributed within different cell types and regulate a variety of cellular processes. To date, some of these interactions have been identified as targets of small molecules or peptides...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luis H. Gutiérrez-González, Selma Rivas-Fuentes, Silvia Guzmán-Beltrán, Angélica Flores-Flores, Jorge Rosas-García, Teresa Santos-Mendoza
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/80792aa8f59444318df3a4b1f8dd9c2c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:80792aa8f59444318df3a4b1f8dd9c2c
record_format dspace
spelling oai:doaj.org-article:80792aa8f59444318df3a4b1f8dd9c2c2021-11-11T18:23:47ZPeptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases10.3390/molecules262163671420-3049https://doaj.org/article/80792aa8f59444318df3a4b1f8dd9c2c2021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6367https://doaj.org/toc/1420-3049PDZ (postsynaptic density (PSD95), discs large (Dlg), and zonula occludens (ZO-1)-dependent interactions are widely distributed within different cell types and regulate a variety of cellular processes. To date, some of these interactions have been identified as targets of small molecules or peptides, mainly related to central nervous system disorders and cancer. Recently, the knowledge of PDZ proteins and their interactions has been extended to various cell types of the immune system, suggesting that their targeting by viral pathogens may constitute an immune evasion mechanism that favors viral replication and dissemination. Thus, the pharmacological modulation of these interactions, either with small molecules or peptides, could help in the control of some immune-related diseases. Deeper structural and functional knowledge of this kind of protein–protein interactions, especially in immune cells, will uncover novel pharmacological targets for a diversity of clinical conditions.Luis H. Gutiérrez-GonzálezSelma Rivas-FuentesSilvia Guzmán-BeltránAngélica Flores-FloresJorge Rosas-GarcíaTeresa Santos-MendozaMDPI AGarticlePDZ domainsPDZ-dependent interactionspeptide inhibitorsimmune-related disordersOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6367, p 6367 (2021)
institution DOAJ
collection DOAJ
language EN
topic PDZ domains
PDZ-dependent interactions
peptide inhibitors
immune-related disorders
Organic chemistry
QD241-441
spellingShingle PDZ domains
PDZ-dependent interactions
peptide inhibitors
immune-related disorders
Organic chemistry
QD241-441
Luis H. Gutiérrez-González
Selma Rivas-Fuentes
Silvia Guzmán-Beltrán
Angélica Flores-Flores
Jorge Rosas-García
Teresa Santos-Mendoza
Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
description PDZ (postsynaptic density (PSD95), discs large (Dlg), and zonula occludens (ZO-1)-dependent interactions are widely distributed within different cell types and regulate a variety of cellular processes. To date, some of these interactions have been identified as targets of small molecules or peptides, mainly related to central nervous system disorders and cancer. Recently, the knowledge of PDZ proteins and their interactions has been extended to various cell types of the immune system, suggesting that their targeting by viral pathogens may constitute an immune evasion mechanism that favors viral replication and dissemination. Thus, the pharmacological modulation of these interactions, either with small molecules or peptides, could help in the control of some immune-related diseases. Deeper structural and functional knowledge of this kind of protein–protein interactions, especially in immune cells, will uncover novel pharmacological targets for a diversity of clinical conditions.
format article
author Luis H. Gutiérrez-González
Selma Rivas-Fuentes
Silvia Guzmán-Beltrán
Angélica Flores-Flores
Jorge Rosas-García
Teresa Santos-Mendoza
author_facet Luis H. Gutiérrez-González
Selma Rivas-Fuentes
Silvia Guzmán-Beltrán
Angélica Flores-Flores
Jorge Rosas-García
Teresa Santos-Mendoza
author_sort Luis H. Gutiérrez-González
title Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
title_short Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
title_full Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
title_fullStr Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
title_full_unstemmed Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
title_sort peptide targeting of pdz-dependent interactions as pharmacological intervention in immune-related diseases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/80792aa8f59444318df3a4b1f8dd9c2c
work_keys_str_mv AT luishgutierrezgonzalez peptidetargetingofpdzdependentinteractionsaspharmacologicalinterventioninimmunerelateddiseases
AT selmarivasfuentes peptidetargetingofpdzdependentinteractionsaspharmacologicalinterventioninimmunerelateddiseases
AT silviaguzmanbeltran peptidetargetingofpdzdependentinteractionsaspharmacologicalinterventioninimmunerelateddiseases
AT angelicafloresflores peptidetargetingofpdzdependentinteractionsaspharmacologicalinterventioninimmunerelateddiseases
AT jorgerosasgarcia peptidetargetingofpdzdependentinteractionsaspharmacologicalinterventioninimmunerelateddiseases
AT teresasantosmendoza peptidetargetingofpdzdependentinteractionsaspharmacologicalinterventioninimmunerelateddiseases
_version_ 1718431831709188096